BioSpace News Archive

The Insight Partner’s dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

The “Global Orthopedic Equipment Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis.

Today, the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, announced a major milestone in Canada’s strategy to rebuild the biomanufacturing and life sciences sector.

Surge in awareness regarding drug abuse, stringent regulations regarding drug abuse, and development of innovative drug testing equipment facilitate the growth in the global drug abuse testing market.

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a Memorandum of Understanding (MoU) with the government of Canada to build a state-of-the-art messenger RNA (mRNA) vaccine manufacturing facility in Canada including access to Moderna’s mRNA development engine.

Medtronic plc (NYSE:MDT) announced today that it will report financial results for its first quarter of fiscal year 2022 on Tuesday, August 24, 2021

MyMD Pharmaceuticals, Inc. reported that its subsidiary Oravax Medical Inc., partially owned with its majority partner Oramed Pharmaceuticals Inc., is preparing to commence clinical trials for its oral COVID-19 vaccine, first in Israel, then in additional clinical sites internationally.

Indapta Therapeutics , Inc. today announced the publication of new preclinical data in Blood Advances demonstrating Indapta’s proprietary allogeneic FcεRIγ-deficient G-NK cells in combination with an FDA-approved monoclonal antibody (mAb)

GenieMD, Inc. (“GenieMD”), GenieMD, provider of a HIPAA-compliant, cloud-based, mobile-first virtual care services platform, supporting several different care engagement modalities is announcing the official launch of their Remote Patient Monitoring solution – which is integrated with their globally deployed iVisit Telehealth solution.

On August 10th, 2021，Belief Biomed announced that China’s National Medical Products Administration (NMPA) has cleared the IND (Investigational New Drug) application for Belief Biomed’s BBM-H901.